Expertise
Our Expertise
INNOVATIVE HEALTHCARE RESEARCH
Ensuring top-quality analytical control across raw materials, APIs, finished products, and packaging requires accuracy, dependability, and rapid results. Our advanced laboratories deliver extensive quality testing services aligned with FDA, EMA, USP, BP, and JP standards, as well as client-specific requirements. Leveraging our worldwide lab network, clients enjoy localized support, fast turnaround times, precise analytical testing, and cost-efficient API production.
Our pharmaceutical portfolio includes:
Acetylcholinesterase Inhibitors
These medicines function by blocking the enzyme responsible for breaking down acetylcholine in the brain, promoting better communication between nerve cells.
- Donepezil (Aricept)
- Rivastigmine (Exelon)
- Galantamine (Reminyl)
(Donepezil is also used to treat more severe Alzheimer’s disease).
COMPREHENSIVE API SERVICES: DESIGN, MANUFACTURING & PROFESSIONAL CONSULTING
JF PHARMA CONSULTING LIMITED specializes in the production of active pharmaceutical ingredients for the pharmaceutical industry, prioritizing superior quality and efficacy. We support our clients with a full spectrum of services, including strategic planning for early-phase drug development, alignment of strategies with regulatory authorities, drafting and finalizing official trial documents, and providing in-depth scientific and medical expertise.
JF PHARMA CONSULTING LIMITED conducts a broad spectrum of advanced clinical studies on APIs and other pharmaceutical materials to support validation and beta-phase data generation. Our medical teams bring extensive expertise in overseeing Phase I trials involving both healthy volunteers and patients, as well as Phase II and Phase III studies across a wide range of therapeutic areas.
To ensure rapid, high-quality patient enrollment, we apply a consultative, cross-disciplinary trial design approach supported by an extensive global network of investigators, leading scientists, and key opinion leaders.
Our strengths in clinical trial management allow us to deliver reliable feasibility assessments, streamlined project initiation, and efficient site activation. We are internationally recognized for comprehensive, end-to-end clinical trial execution, with a consistent record of success across multiple therapeutic domains, particularly in:
- Infectious Diseases
- Neurological Disorders
- Respiratory Conditions
GENETIC ENGINEERING & SYNTHETIC CHEMISTRY
The foundation of recombinant DNA technology lies in manipulating genetic material beyond the organism to generate improved biological characteristics or medically valuable products. Supported by specialized research and proprietary processes, we provide next-generation medical solutions. The approach includes integrating selected DNA segments from diverse origins into appropriate vectors to express specific genes.
We apply recombinant DNA methodologies, gene therapy techniques, and genetic modification strategies in both environmental remediation and the treatment of severe medical conditions. Driven by ongoing advancements and wide-ranging applications in this field, we have optimized our processes to maximize therapeutic effectiveness for patient use.
BIOLOGICAL SAFETY ASSESSMENT
At JF PHARMA CONSULTING LIMITED, biosafety assurance is delivered by highly trained scientific and bioengineering teams using internationally recognized methodologies. Our capabilities include sterility verification through direct inoculation and membrane filtration (EP 2.6.1), automated alternative sterility techniques, bacterial endotoxin measurement (EP 2.6.14, USP), cytotoxicity evaluation (ISO 10993-5, USP), and in-vitro pyrogen testing (EP 2.6.30). Advanced microbial identification is performed using platforms such as VITEK®2 and API systems.
We provide full viral safety evaluation in accordance with EP 2.6.16, EP 5.2.3, and ICH Q5A, including in-vitro adventitious virus testing and mycoplasma detection (EP 2.6.7, FDA). These assessments cover cell banks, starting materials, intermediate and final products, viral seed stocks, animal-derived tissues, and cell-based materials.
In addition, we perform purified reference product (PRP) testing to support biologics and recombinant protein manufacturing. Our biosafety expertise extends to monoclonal antibodies, viral vaccines, cell therapies, and gene therapy products.
Subscribe to our newsletter
Subscribe to our newsletter
© 2026 JF Pharma CONSULTING. All rights reserved
RC 07945999
Registered in England and Wales